Patient characteristics
ID . | Age (y) . | Sex . | Concurrent diagnosis . | CMV IgG/IgM . | Time GPIneg neutrophils > 1.0% (mo) . | Time GPIneg neutrophil >75% (mo) . | NK cell number (/µL)* . | GPIneg neutrophil at analysis (%) . |
---|---|---|---|---|---|---|---|---|
1 | 23 | Male | AA | +/− | 78.2 | 78.2 | 41 | 99.2 |
2 | 43 | Male | AA | +/+ | 109 | 38.7 | 213 | 99.1 |
3 | 42 | Female | AA | +/− | 30.3 | 30.3 | 78 | 97.8 |
4 | 28 | Female | AA | +/− | 48.8 | 12.4 | NA | 97.6 |
5 | 36 | Female | AA | −/− | 131.6 | 100.8 | 75 | 97.3 |
6 | 33 | Male | AA | +/− | 61.4 | 36.6 | 91 | 95.2 |
7 | 60 | Female | AA/MDS | +/− | 15.1 | 5.2 | 141 | 85.1 |
8 | 67 | Female | AA | +/− | 75.1 | 0.0 | 55 | 84.4 |
9 | 29 | Male | AA | +/− | 17.7 | 11.7 | 184 | 77.1 |
10 | 59 | Male | AA | −/− | 38.6 | NR | 120 | 62.8 |
11 | 60 | Female | AA | +/− | 76 | NR | 71 | 48.3 |
12 | 61 | Male | AA | −/− | 17.2 | NR | 78 | 46.8 |
13 | 21 | Male | AA | +/− | 3.5 | NR | 198 | 44.7 |
14 | 32 | Female | AA | −/− | 158.4 | NR | 88 | 23.1 |
15 | 40 | Female | AA | +/− | 14.5 | NR | 116 | 17.8 |
ID . | Age (y) . | Sex . | Concurrent diagnosis . | CMV IgG/IgM . | Time GPIneg neutrophils > 1.0% (mo) . | Time GPIneg neutrophil >75% (mo) . | NK cell number (/µL)* . | GPIneg neutrophil at analysis (%) . |
---|---|---|---|---|---|---|---|---|
1 | 23 | Male | AA | +/− | 78.2 | 78.2 | 41 | 99.2 |
2 | 43 | Male | AA | +/+ | 109 | 38.7 | 213 | 99.1 |
3 | 42 | Female | AA | +/− | 30.3 | 30.3 | 78 | 97.8 |
4 | 28 | Female | AA | +/− | 48.8 | 12.4 | NA | 97.6 |
5 | 36 | Female | AA | −/− | 131.6 | 100.8 | 75 | 97.3 |
6 | 33 | Male | AA | +/− | 61.4 | 36.6 | 91 | 95.2 |
7 | 60 | Female | AA/MDS | +/− | 15.1 | 5.2 | 141 | 85.1 |
8 | 67 | Female | AA | +/− | 75.1 | 0.0 | 55 | 84.4 |
9 | 29 | Male | AA | +/− | 17.7 | 11.7 | 184 | 77.1 |
10 | 59 | Male | AA | −/− | 38.6 | NR | 120 | 62.8 |
11 | 60 | Female | AA | +/− | 76 | NR | 71 | 48.3 |
12 | 61 | Male | AA | −/− | 17.2 | NR | 78 | 46.8 |
13 | 21 | Male | AA | +/− | 3.5 | NR | 198 | 44.7 |
14 | 32 | Female | AA | −/− | 158.4 | NR | 88 | 23.1 |
15 | 40 | Female | AA | +/− | 14.5 | NR | 116 | 17.8 |
AA, aplastic anemia; MDS, myelodysplastic syndrome; NA, not available; NR, not reached.
Normal range, 126 to 729/µL.